Colorectal cancer screening beliefs. Focus groups with first-degree relatives.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 10732537)

Published in Cancer Pract on April 07, 2000

Authors

S M Rawl1, U Menon, V L Champion, J L Foster, C S Skinner

Author Affiliations

1: Indiana University School of Nursing, Indianapolis 46202, USA.

Associated clinical trials:

Increasing Colorectal and Breast Cancer Screening in Women (COBRA) | NCT03279198

Articles citing this

Patient-reported barriers to colorectal cancer screening: a mixed-methods analysis. Am J Prev Med (2010) 1.98

The relative importance of patient-reported barriers to colorectal cancer screening. Am J Prev Med (2010) 1.68

Beliefs associated with fecal occult blood test and colonoscopy use at a worksite colon cancer screening program. J Occup Environ Med (2003) 1.20

Using a computer to teach patients about fecal occult blood screening. A randomized trial. J Gen Intern Med (2005) 1.14

Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health (2006) 1.10

Strategies for in-person recruitment: lessons learned from a New Jersey primary care research network (NJPCRN) study. J Am Board Fam Med (2010) 0.94

Patient trust in physician influences colorectal cancer screening in low-income patients. Am J Prev Med (2014) 0.92

Perceived obstacles of colorectal cancer screening and their associated factors among 10,078 Chinese participants. PLoS One (2013) 0.89

Integrating men's health and masculinity theories to explain colorectal cancer screening behavior. Am J Mens Health (2013) 0.85

Black white disparities in receiving a physician recommendation for colorectal cancer screening and reasons for not undergoing screening. J Health Care Poor Underserved (2013) 0.85

Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in France. BMC Cancer (2010) 0.82

Interactions among physicians, patients, and first-degree relatives in the familial screening of colorectal cancer in France. Patient Prefer Adherence (2008) 0.79

Increasing colorectal cancer testing: translating physician interventions into population-based practice. Health Care Financ Rev (2006) 0.76

Development and Psychometric Evaluation of the Lung Cancer Screening Health Belief Scales. Cancer Nurs (2016) 0.75

Shared decision-making about colorectal cancer screening: a conceptual framework to guide research. Patient Educ Couns (2013) 0.75

Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study. Health Psychol Res (2013) 0.75

Articles by these authors

Screening for ovarian cancer: a pilot randomised controlled trial. Lancet (1999) 5.81

Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet (2003) 5.39

The effects of computer-tailored smoking cessation messages in family practice settings. J Fam Pract (1994) 3.76

Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol (1976) 3.55

Tailoring: what's in a name? Health Educ Res (2000) 3.32

New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92

Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. Br J Cancer (1975) 2.39

Are patients of women physicians screened more aggressively? A prospective study of physician gender and screening. J Gen Intern Med (1995) 2.16

Factors affecting visualization of postmenopausal ovaries: descriptive study from the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Ultrasound Obstet Gynecol (2013) 2.11

Instrument development for health belief model constructs. ANS Adv Nurs Sci (1984) 1.86

Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. Br J Cancer (1976) 1.77

Demonstration of radiosensitization of hypoxic cells in solid tumours by metronidazole. Br J Radiol (1974) 1.77

Metronidazole ("Flagyl"). A radiosensitizer of hypoxic cells. Br J Radiol (1974) 1.68

Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med (2001) 1.58

Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiol Biomarkers Prev (2001) 1.55

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer (2009) 1.54

Human studies with "high dose" metronidazole: a non-toxic radiosensitizer of hypoxic cells. Br J Cancer (1975) 1.47

Attitudes about breast cancer and mammography: racial, income, and educational differences. Women Health (1997) 1.46

Radiosensitization of anoxic cells by metronidazole. Br J Radiol (1973) 1.40

Validity of self-reported mammography in low-income African-American women. Am J Prev Med (1998) 1.39

Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer (1974) 1.35

Hepatic pyruvate kinase. Regulation by glucagon, cyclic adenosine 3'-5'-monophosphate, and insulin in the perfused rat liver. J Biol Chem (1976) 1.31

Adrenergic control of glucose output and adenosine 3':5'-monophosphate levels in hepatocytes from juvenile and adult rats. J Biol Chem (1979) 1.30

Factors associated with repeat mammography screening. J Fam Pract (2000) 1.30

Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status. BJOG (2011) 1.23

Taxonomy and pathogenicity of Erwinia cacticida sp. nov. Int J Syst Bacteriol (1991) 1.23

Psychological morbidity associated with ovarian cancer screening: results from more than 23,000 women in the randomised trial of ovarian cancer screening (UKCTOCS). BJOG (2014) 1.22

Influences on multidisciplinary team decision-making. Int J Gynecol Cancer (2007) 1.19

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. Br J Cancer (2009) 1.19

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study. Br J Cancer (2010) 1.18

Lentivirus Nef specifically activates Pak2. J Virol (2000) 1.18

Predicting mammography and breast self-examination in African American women. Cancer Nurs (1997) 1.17

Do benefits and barriers differ by stage of adoption for colorectal cancer screening? Health Educ Res (2004) 1.17

Electron affinic sensitization. II. Para-nitroacetophenone: a radiosensitizer for anoxic bacterial and mammalian cells. Int J Radiat Biol Relat Stud Phys Chem Med (1971) 1.17

Feasibility of screening for ovarian cancer using symptoms as selection criteria. BJOG (2007) 1.15

The effects of standard care counseling or telephone/in-person counseling on beliefs, knowledge, and behavior related to mammography screening. Oncol Nurs Forum (2001) 1.14

The amphotropic murine leukemia virus receptor gene encodes a 71-kilodalton protein that is induced by phosphate depletion. J Virol (1997) 1.13

Cost-effectiveness comparison of five interventions to increase mammography screening. Prev Med (1999) 1.12

Improving depressive symptoms among caregivers of patients with cancer: results of a randomized clinical trial. Oncol Nurs Forum (2001) 1.12

Examining the boundaries of tailoring: the utility of tailoring versus targeting mammography interventions for two distinct populations. Health Educ Res (2001) 1.11

Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening. Ultrasound Obstet Gynecol (2012) 1.11

Women's interest in chemoprevention for breast cancer. Arch Intern Med (2001) 1.10

The potential of computers in patient education. Patient Educ Couns (1993) 1.10

A comparison of national cancer registry and direct follow-up in the ascertainment of ovarian cancer. Br J Cancer (1999) 1.10

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. Br J Cancer (2009) 1.08

Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology (1999) 1.08

Acute hormonal control of pyruvate kinase and lactate formation in the isolated rat hepatocyte. Arch Biochem Biophys (1978) 1.04

Risk beliefs and interest in counseling: focus-group interviews among first-degree relatives of breast cancer patients. J Cancer Educ (1999) 1.03

Microbial colonization of injured cactus tissue (Stenocereus gummosus) and its relationship to the ecology of cactophilic Drosophila mojavensis. Appl Environ Microbiol (1989) 1.02

Development and validation of a Structured Telephone Interview for Dementia Assessment (STIDA): the NIMH Genetics Initiative. J Geriatr Psychiatry Neurol (1997) 0.99

Crosscultural comparison on nursing image. Int J Nurs Stud (1985) 0.98

Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening. Br J Cancer (2010) 0.98

Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10,418 British women aged 54-65. BJOG (2011) 0.98

Factors influencing compliance with home exercise programs among patients with upper-extremity impairment. Am J Occup Ther (1999) 0.98

Induction by alkaloids and phenobarbital of Family 4 Cytochrome P450s in Drosophila: evidence for involvement in host plant utilization. Mol Gen Genet (1998) 0.98

Alternate binding of actin and calmodulin to multiple sites on dystrophin. J Biol Chem (1995) 0.97

Early detection of cancer in the general population: a blinded case-control study of p53 autoantibodies in colorectal cancer. Br J Cancer (2012) 0.96

Postmenopausal women undergoing transvaginal ultrasound screening prefer not to have chaperones. BJOG (2006) 0.96

Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582. Br J Radiol (1976) 0.95

Surgical morbidity associated with radical trachelectomy and radical hysterectomy. Gynecol Oncol (2005) 0.95

Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol (2012) 0.94

Mammography in older women: one-time and three-year adherence to guidelines. Nurs Res (1996) 0.93

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer. Br J Cancer (2013) 0.92

Autophosphorylation of cGMP-dependent protein kinase. J Biol Chem (1981) 0.92

Use of the health belief model in determining frequency of breast self-examination. Res Nurs Health (1985) 0.90

Experience of symptoms indicative of gynaecological cancers in UK women. Br J Cancer (2013) 0.89

Tailoring interventions for health behavior change in breast cancer screening. Cancer Pract (1997) 0.89

Mammography in women > or = 50 years of age. Predisposing and enabling characteristics. Cancer Nurs (1993) 0.89

Health beliefs and social influence in home safety practices of mothers with preschool children. Image J Nurs Sch (1996) 0.88

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis. BJOG (2012) 0.86

The impact of age and race on mammography practices. Health Care Women Int (2002) 0.86

Pituitary abscess: an unusual presentation of "aseptic meningitis". J Pediatr Endocrinol Metab (1995) 0.86

Radiosensitization of hypoxic cells by metronidazole (Flagyl). Br J Radiol (1973) 0.85

Psychological factors related to stage of mammography adoption. J Womens Health Gend Based Med (1999) 0.84

Lentiviral and murine retroviral transduction of T cells for expression of human CD40 ligand. Hum Gene Ther (2000) 0.84

Carbohydrate fluxes into alginate biosynthesis in Azotobacter vinelandii NCIB 8789: NMR investigations of the triose pools. Biochemistry (1996) 0.84

Serum oestrogen receptor alpha and beta bioactivity are independently associated with breast cancer: a proof of principle study. Br J Cancer (2009) 0.84

Novel one-stop multidisciplinary follow-up clinic significantly improves cancer risk management in BRCA1/2 carriers. Fam Cancer (2010) 0.84

Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteomics (2015) 0.83

The beet western yellows virus ST9-associated RNA shares structural and nucleotide sequence homology with carmo-like viruses. Virology (1993) 0.83

Analysis of biological reference materials, prepared by microwave dissolution, using inductively coupled plasma mass spectrometry. Analyst (1990) 0.82

Interleukin 1 beta propeptide is detected intracellularly and extracellularly when human monocytes are stimulated with LPS in vitro. J Exp Med (1994) 0.82

Patient-reporting improves estimates of postoperative complication rates: a prospective cohort study in gynaecological oncology. Br J Cancer (2013) 0.82

Adrenergic control of glycolysis and pyruvate kinase activity in hepatocytes from young and old rats. J Biol Chem (1979) 0.82

The relationship of support, availability, and attitude to research utilization. J Nurs Adm (1986) 0.81

Drosophila cAMP-dependent protein kinase. J Biol Chem (1984) 0.81

Structural and functional correlates between HIV-1 and SIV Nef isolates. Virology (1996) 0.81

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening. Br J Cancer (2012) 0.81

Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cells. Int J Radiat Oncol Biol Phys (1978) 0.81

Patient Motivation, Satisfaction, and Coping in Genetic Counseling and Testing for BRCA1 and BRCA2. J Genet Couns (2000) 0.80

Prenatal health behaviors as predictors of breast-feeding, injury, and vaccination. Arch Pediatr Adolesc Med (1995) 0.79